🇦🇹 Austria Country × Condition
breast cancer Clinical Trials in Austria
Active clinical trials for breast cancer with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Enrollment
1,000 pts
Country
🇦🇹 Austria
Olema Pharmaceuticals, Inc.
View Trial → NCT07140172
Recruiting
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Enrollment
1,060 pts
Country
🇦🇹 Austria
University Hospital, Basel, Switzer...
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in Austria?
There are currently 2 active clinical trials for breast cancer with sites in Austria, of which 2 are actively recruiting patients.
How can I join a breast cancer clinical trial in Austria?
To join a breast cancer clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Austria?
Active breast cancer trials in Austria span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology